![William Arthur Bains](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Arthur Bains
Fondateur chez Five Alarm Bio Ltd.
Profil
William Arthur Bains is the founder of Amedis Pharmaceuticals Ltd.
(1999) and Five Alarm Bio Ltd.
(2016), where he held the titles of Chief Executive & Scientific Officer and Chief Scientific Officer, respectively.
Dr. Bains is also the founder of Delta-G Ltd.
He held former positions as a Non-Executive Director at Karus Therapeutics Ltd.
(2005-2012) and as a Director, Principal at Iksuda Therapeutics Ltd., Vectura Group Ltd., Pa Consulting Group Ltd., and Ark Therapeutics Group Plc.
Dr. Bains received his undergraduate degree from the University of Oxford and his doctorate from the University of Warwick.
Postes actifs de William Arthur Bains
Sociétés | Poste | Début |
---|---|---|
Five Alarm Bio Ltd.
![]() Five Alarm Bio Ltd. Pharmaceuticals: MajorHealth Technology Five Alarm Bio Ltd. is a drug discovery firm that develops compounds that boost bodies’ ability to defend self against the damage of aging. It focuses on novel approaches to anti-aging, with broad potential therapeutic application. The company was founded by William Arthur Bains, Sunil Rajen Shah, and Ann Baker in 2016 and is headquartered in Cambridge, the United Kingdom. | Fondateur | 01/01/2016 |
Anciens postes connus de William Arthur Bains
Sociétés | Poste | Fin |
---|---|---|
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | 12/06/2012 |
Delta-G Ltd. | Fondateur | 16/02/2009 |
Amedis Pharmaceuticals Ltd. | Fondateur | 06/11/2008 |
VECTURA GROUP | Corporate Officer/Principal | - |
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Formation de William Arthur Bains
University of Oxford | Undergraduate Degree |
University of Warwick | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 8 |
---|---|
Vectura Group Ltd.
![]() Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
PA Consulting Group Ltd.
![]() PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Commercial Services |
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Amedis Pharmaceuticals Ltd. | Commercial Services |
Karus Therapeutics Ltd.
![]() Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Delta-G Ltd. | Health Technology |
Iksuda Therapeutics Ltd.
![]() Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
Five Alarm Bio Ltd.
![]() Five Alarm Bio Ltd. Pharmaceuticals: MajorHealth Technology Five Alarm Bio Ltd. is a drug discovery firm that develops compounds that boost bodies’ ability to defend self against the damage of aging. It focuses on novel approaches to anti-aging, with broad potential therapeutic application. The company was founded by William Arthur Bains, Sunil Rajen Shah, and Ann Baker in 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |